| [1] |
Amedeo L，Fabio N，Mauro M，et al.Nonalcoholic fatty liver disease：Evolving paradigms[J].World J Gastroenterol，2017，23（36）：6571-6592.
|
| [2] |
Fan JG，Kim SU，Wong VW.New trends on obesity and NAFLD in Asia[J].J Hepatol，2017，67（4）：862-873.
|
| [3] |
Chao Y，Yang SJ，Xu WW，et al.Association between thehyperuricemia and nonalcoholic fatty liver disease risk in a Chinesepopulation：a retrospective cohort study[J].PLoS One，2017，12（5）：e0177249.
|
| [4] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南（2018年更新版）[J].现代医药卫生，2018，34（5）：641-649.
|
| [5] |
Ivana M，Sandra M，Tamara TW，et al.Nonalcoholic fatty liver disease——a multisystem disease?[J].World J Gas troenterol，2016，22（43）：9488-9505.
|
| [6] |
Younossi ZM，Koenig AB，Abdelatif D，et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence，incidence，and outcomes[J].Hepa tology，2016，64（1）：73-84.
|
| [7] |
Zhu JZ，Zhou QY，Wang YE，et al.Prevalence of fatty liver disease and the economy in China：a systematic review[J].World J Gastroenterol，2015，21（18）：5695-5706.
|
| [16] |
白俊玺，舒仁明，黄勇，等.血尿酸与非酒精性脂肪性肝病发生风险相关性随访队列研究[J].中华肝脏病杂志，2018，26（4）：271-275.
|
| [17] |
Romero G，Zelber S，Treneli M.Treatment of NAFLD with diet，physical activity and exercise[J].J Hepatol，2017，67（4）：829-846.
|
| [8] |
Kwok R，Choi KC，Wong GL，et al.Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements：aprospective cohort study[J].Gut，2016，65（8）：1359-1368.
|
| [9] |
Zhang RN，Zhang RD，Mi YQ，et al.APOC3 rs2070666 is associated with the severity of hepatic steatosis independently of PNPLA3 rs738409 in Chinese patients with nonalcoholic fatty liverdiseases[J].Dig Dis Sci，2016，61（8）：2284-2293.
|
| [10] |
Bedossa P，Flip Pathology Consortium.Utility and appropriateness of the fatty liver inhibition of progression（FLIP）algorithm and steatosis，activity，and fibrosis （SAF） score in the evaluation of biopsies of nonalcoholic fatty liver disease[J].Hepatology，2014，60（2）：565-575.
|
| [11] |
Chitturi S，Wong VW，Chan WK，et al.The Asia Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2：management and special groups[J].J Gastroenterol Hepatol，2018，33（1）：86-98.
|
| [12] |
Xu L，Lu W，Li P，et al.A comparison of hepatic steatosis index，controlled attenuation parameter，and ultrasound as noninvasive diagnostic tools for hepatic steatosis in patients with biopsy-proven chronic hepatitis B[J].Dig Liver Dis，2017，49（8）：910-917.
|
| [13] |
Zhang HJ，Pan LL，Ma ZM，et al.Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults：a 1-year follow up study[J].Diabetes Obes Metab，2017，19（2）：284-289.
|
| [14] |
Zheng XY，Gong LL，Luo R，et al.Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults[J].Lipids Health Dis，2017，16（10）：202.
|
| [15] |
Rosa L，Giuseppina P，Silvia F.Role of serum uric acid and ferritin in the development and progression of NAFLD[J].Int J Mol Sci，2016，17（4）：548.
|
